IKARIAN CAPITAL, LLC – Horizon Therapeutics Public Limited Company Transaction History
IKARIAN CAPITAL, LLC portfolio value:
$5.26M
portfolio value
Horizon Therapeutics Public Limited Company 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | call | Decrease | -14.90% | -14.9K shares | -2.70M | $61.89 | 85.1K |
| Q3 2022 | share | Decrease | -53.65% | -85.89K shares | -8.17M | $61.89 | 74.21K |
| Q2 2022 | share | Increase | +45.41% | 50K shares | 1.18M | $79.76 | 160.11K |
| Q2 2022 | call | Decrease | -36.75% | -58.1K shares | -8.65M | $79.76 | 100K |
| Q1 2022 | call | Decrease | -35.97% | -88.8K shares | -9.97M | $105.21 | 158.1K |
| Q1 2022 | share | Increase | +45.54% | 34.45K shares | 3.43M | $105.21 | 110.11K |
| Q4 2021 | share | Increase | +194.85% | 50K shares | 5.34M | $108.26 | 75.66K |
| Q4 2021 | call | Decrease | -41.48% | -175K shares | -19.60M | $108.26 | 246.9K |
| Q3 2021 | share | Decrease | -53.19% | -29.15K shares | -2.32M | $109.54 | 25.66K |
| Q3 2021 | call | Increase | +68.76% | 171.9K shares | 22.80M | $109.54 | 421.9K |
| Q2 2021 | call | Decrease | -60.46% | -382.2K shares | -34.77M | $93.64 | 250K |
| Q2 2021 | share | Increase | +8990.38% | 54.21K shares | 5.07M | $93.64 | 54.81K |
| Q1 2021 | share | Increase | 0.00% | 603 shares | 56K | $92.04 | 603 |
| Q1 2021 | call | Decrease | -35.30% | -345K shares | -13.29M | $92.04 | 632.2K |
| Q1 2021 | put | Decrease | -100.00% | -265K shares | -19.38M | $92.04 | 0 |
| Q4 2020 | call | Increase | +152.83% | 590.7K shares | 41.46M | $73.15 | 977.2K |
| Q4 2020 | share | Decrease | -100.00% | -2.64K shares | -205K | $73.15 | 0 |
| Q4 2020 | put | Increase | 0.00% | 265K shares | 19.38M | $73.15 | 265K |
| Q3 2020 | call | Increase | 0.00% | 386.5K shares | 30.02M | $77.68 | 386.5K |
| Q3 2020 | share | Increase | 0.00% | 2.64K shares | 205K | $77.68 | 2.64K |